Importantly, the primary tumor demonstrated a much higher proportion of CD103+CD39+ double-positive CD8+ T cells, a cell population associated with improved prognosis in HNSCC (7). This evidence concerns the gene ENTPD1 and head and neck squamous cell carcinoma.